<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Microbiol</journal-id><journal-title>BMC Microbiology</journal-title><issn pub-type="epub">1471-2180</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">19087358</article-id><article-id pub-id-type="pmc">2632671</article-id><article-id pub-id-type="publisher-id">1471-2180-8-223</article-id><article-id pub-id-type="doi">10.1186/1471-2180-8-223</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Characterization of the <italic>ompL1 </italic>gene of pathogenic <italic>Leptospira species </italic>in China and cross-immunogenicity of the OmpL1 protein</article-title></title-group><contrib-group><contrib id="A1" contrib-type="author"><name><surname>Dong</surname><given-names>Haiyan</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>yanzidong1973@hotmail.com</email></contrib><contrib id="A2" contrib-type="author"><name><surname>Hu</surname><given-names>Ye</given-names></name><xref ref-type="aff" rid="I3">3</xref><email>huye8254@sina.com</email></contrib><contrib id="A3" contrib-type="author"><name><surname>Xue</surname><given-names>Feng</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>sherlock_hsueh@hotmail.com</email></contrib><contrib id="A4" contrib-type="author"><name><surname>Sun</surname><given-names>Dexter</given-names></name><xref ref-type="aff" rid="I4">4</xref><email>dextersun@sinaunitedhealth.com</email></contrib><contrib id="A5" contrib-type="author"><name><surname>Ojcius</surname><given-names>David M</given-names></name><xref ref-type="aff" rid="I5">5</xref><email>dojcius@ucmerced.edu</email></contrib><contrib id="A6" contrib-type="author"><name><surname>Mao</surname><given-names>Yafei</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>myf@zju.edu.cn</email></contrib><contrib id="A7" corresp="yes" contrib-type="author"><name><surname>Yan</surname><given-names>Jie</given-names></name><xref ref-type="aff" rid="I1">1</xref><xref ref-type="aff" rid="I2">2</xref><email>med_bp@zju.edu.cn</email></contrib></contrib-group><aff id="I1"><label>1</label>Division of Basic Medical Microbiology, State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, the First Affiliated Hospital of Medical College, Zhejiang University, Hangzhou Zhejiang, PR China</aff><aff id="I2"><label>2</label>Department of Medical Microbiology and Parasitology, Medical College of Zhejiang University, Hangzhou Zhejiang, PR China</aff><aff id="I3"><label>3</label>Medical School of Jinhua Professional Technique College, Jinhua Zhejiang, PR China</aff><aff id="I4"><label>4</label>New York Presbyterian Hospital &#x00026; Hospital for Special Surgery, Weill Medical College, Cornell University, New York, NY, USA</aff><aff id="I5"><label>5</label>School of Natural Sciences, University of California, Merced, CA, USA</aff><pub-date pub-type="collection"><year>2008</year></pub-date><pub-date pub-type="epub"><day>17</day><month>12</month><year>2008</year></pub-date><volume>8</volume><fpage>223</fpage><lpage>223</lpage><ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2180/8/223"/><history><date date-type="received"><day>1</day><month>9</month><year>2008</year></date><date date-type="accepted"><day>17</day><month>12</month><year>2008</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2008 Dong et al; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2008</copyright-year><copyright-holder>Dong et al; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0"/>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p><!--<rdf xmlns="http://web.resource.org/cc/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1" xmlns:dcterms="http://purl.org/dc/terms"><Work xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" rdf:about=""><license rdf:resource="http://creativecommons.org/licenses/by/2.0"/><dc:type rdf:resource="http://purl.org/dc/dcmitype/Text"/><dc:author>               Dong               Haiyan                                             yanzidong1973@hotmail.com            </dc:author><dc:title>            Characterization of the ompL1 gene of pathogenic Leptospira species in China and cross-immunogenicity of the OmpL1 protein         </dc:title><dc:date>2008</dc:date><dcterms:bibliographicCitation>BMC Microbiology 8(1): 223-. (2008)</dcterms:bibliographicCitation><dc:identifier type="sici">1471-2180(2008)8:1&#x0003c;223&#x0003e;</dc:identifier><dcterms:isPartOf>urn:ISSN:1471-2180</dcterms:isPartOf><License rdf:about="http://creativecommons.org/licenses/by/2.0"><permits rdf:resource="http://web.resource.org/cc/Reproduction" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/Distribution" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Notice" xmlns=""/><requires rdf:resource="http://web.resource.org/cc/Attribution" xmlns=""/><permits rdf:resource="http://web.resource.org/cc/DerivativeWorks" xmlns=""/></License></Work></rdf>--></license></permissions><abstract><sec><title>Background</title><p>The usefulness of available vaccine and serological tests for leptospirosis is limited by the low cross-reactivity of antigens from numerous serovars of pathogenic <italic>Leptospira </italic>spp. Identification of genus-specific protein antigens (GP-Ag) of <italic>Leptospira </italic>would be important for development of universal vaccines and serodiagnostic methods. OmpL1, a transmembrane porin of pathogenic leptospires, was identified as a possible GP-Ag, but its sequence diversity and immune cross-reactivity among different serovars of pathogenic leptospires remains largely unknown.</p></sec><sec><title>Results</title><p>PCR analysis demonstrated that the <italic>ompL1 </italic>gene existed in all 15 official Chinese standard strains as well as 163 clinical strains of pathogenic leptospires isolated in China. In the standard strains, the <italic>ompL1 </italic>gene could be divided into three groups (<italic>ompL1/1</italic>, <italic>ompL1/2 </italic>and <italic>ompL1/3</italic>) according to their sequence identities. Immune electron microscopy demonstrated that all products of the different gene types of <italic>ompL1 </italic>are located on the surface of leptospires. The microscopic agglutination test revealed extensive yet distinct cross-immunoagglutination among the antisera against recombinant OmpL1 (rOmpL1) and leptospiral strains belonging to different <italic>ompL1 </italic>gene types. These cross-immunoreactions were further verified by ELISAs using the OmpL1 proteins as the coated antigens in serum samples from 385 leptospirosis patients. All the antisera against rOmpL1 proteins could inhibit <italic>L. interrogans </italic>strain Lai from adhering to J774A.1 cells. Furthermore, immunization of guinea pigs with each of the rOmpL1 proteins could cause cross-immunoprotection against lethal challenge with leptospires from different <italic>ompL1 </italic>gene types.</p></sec><sec><title>Conclusion</title><p>Three types of the <italic>ompL1 </italic>gene are present in pathogenic leptospires in China. OmpL1 is an immunoprotective GP-Ag which should be considered in the design of new universal vaccines and serodiagnostic methods against leptospirosis.</p></sec></abstract></article-meta></front><body><sec><title>Background</title><p>Leptospirosis, caused by infection with pathogenic <italic>Leptospira </italic>species belonging to different serogroups and serovars, is one of the most prevalent zoonotic diseases in the world [<xref ref-type="bibr" rid="B1">1</xref>-<xref ref-type="bibr" rid="B3">3</xref>]. A wide variety of serogroups and serovars have been identified along with endemicity which varies from region to region [<xref ref-type="bibr" rid="B4">4</xref>-<xref ref-type="bibr" rid="B6">6</xref>]. The leptospiral vaccines used currently are mainly multivalent dead whole-cell mixtures made of several local dominant serovars in different countries and regions. These vaccines, however, do not confer cross-protective immunity to the serogroups that are not represented in the vaccine [<xref ref-type="bibr" rid="B7">7</xref>,<xref ref-type="bibr" rid="B8">8</xref>], allowing the unrepresented serovars to continue causing outbreaks of leptospirosis. For instance, in a central province, Anhui, and an eastern province, Zhejiang, of China, <italic>L. interrogans </italic>serogroup Sejroe serovar Medanensis caused local outbreaks of leptospirosis [<xref ref-type="bibr" rid="B9">9</xref>-<xref ref-type="bibr" rid="B12">12</xref>]. In addition, vaccination with the whole-cell vaccines may lead to incomplete, short-term immunity as well as serious side effects [<xref ref-type="bibr" rid="B13">13</xref>-<xref ref-type="bibr" rid="B15">15</xref>]. A universal vaccine against leptospirosis is not available yet, making the identification of genus-specific protein antigens (GP-Ag) that display extensive cross-immunity very valuable for developing new vaccines and serodiagnostic methods.</p><p>Outer membrane proteins (Omps) are important pathogenic components and highly conserved in different serogroups and serovars of pathogenic leptospires. OmpL1, a transmembrane Omp with 320 amino acid residues, first reported by Haake and his colleagues in 1993, is a porin expressed by all the tested pathogenic <italic>Leptospira </italic>species [<xref ref-type="bibr" rid="B16">16</xref>-<xref ref-type="bibr" rid="B19">19</xref>]. However, the diversity of <italic>ompL1 </italic>gene sequences from different pathogenic <italic>Leptospira </italic>spp. and the distribution of the <italic>ompL1 </italic>gene in clinical isolates had not been characterized until now. Moreover, the cross-immunogenicity and immunoprotective effects of OmpL1 were mostly unknown.</p><p>In this study, we sequenced and analyzed <italic>ompL1 </italic>genes cloned from standard pathogenic strains of leptospires prevalent in China. Several prokaryotic recombinant products of the gene (rOmpL1) were expressed and their rabbit antisera were prepared. rOmpL1-based ELISAs were established to examine specific antibodies in sera from leptospirosis patients. In parallel, the microscopic agglutination test (MAT) was performed to detect the cross-immunoagglutination of different antisera against rOmpL1 proteins, and immunoelectron microscopy (IEM) was employed to localize OmpL1 on the leptospires. Finally, immunoprotection of rOmpL1 was tested in guinea pigs. Taken together, our results suggest that OmpL1 could be used as a major component of a universal and efficient immunogen for vaccination and also for diagnosis of leptospirosis.</p></sec><sec><title>Results</title><sec><title>Amplification of <italic>ompL1 </italic>genes in the standard and clinical strains</title><p>All the 15 standard strains and 163 isolates of pathogenic <italic>Leptospira </italic>species (Table <xref ref-type="table" rid="T1">1</xref>) carried the <italic>ompL1 </italic>gene, since amplicons with the expected size were produced by PCR from all the strains and isolates (data no shown).</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Background information on the leptospiral strains and serum specimens</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Strain/Sera</td><td align="left">Serovar</td><td align="left">Serogroup</td><td align="left">Genospecies</td></tr></thead><tbody><tr><td align="left">Standard strains (n = 15)</td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;Lai</td><td align="left">Lai</td><td align="left">Icterohaemorrhagiae</td><td align="left"><italic>L. interrogans</italic></td></tr><tr><td align="left">&#x02003;Lin</td><td align="left">Canicola</td><td align="left">Canicola</td><td align="left"><italic>L. interrogans</italic></td></tr><tr><td align="left">&#x02003;Tian</td><td align="left">Pyrogenes</td><td align="left">Pyrogenes</td><td align="left"><italic>L. interrogans</italic></td></tr><tr><td align="left">&#x02003;Lin 4</td><td align="left">Autumnalis</td><td align="left">Autumnalis</td><td align="left"><italic>L. interrogans</italic></td></tr><tr><td align="left">&#x02003;65-9</td><td align="left">Australis</td><td align="left">Australis</td><td align="left"><italic>L. interrogans</italic></td></tr><tr><td align="left">&#x02003;Luo</td><td align="left">Pomona</td><td align="left">Pomona</td><td align="left"><italic>L. interrogans</italic></td></tr><tr><td align="left">&#x02003;Lin 6</td><td align="left">Grippotyphosa</td><td align="left">Grippotyphosa</td><td align="left"><italic>L. interrogans</italic></td></tr><tr><td align="left">&#x02003;P 7</td><td align="left">Hebdomadis</td><td align="left">Hebdomadis</td><td align="left"><italic>L. interrogans</italic></td></tr><tr><td align="left">&#x02003;L 37</td><td align="left">Paidjan</td><td align="left">Bataviae</td><td align="left"><italic>L. interrogans</italic></td></tr><tr><td align="left">&#x02003;L 183</td><td align="left">Wolffi</td><td align="left">Sejroe</td><td align="left"><italic>L. interrogans</italic></td></tr><tr><td align="left">&#x02003;M 10</td><td align="left">Javanica</td><td align="left">Javanica</td><td align="left"><italic>L. borgpetersenii</italic></td></tr><tr><td align="left">&#x02003;Pishu</td><td align="left">Ballum</td><td align="left">Ballum</td><td align="left"><italic>L. borgpetersenii</italic></td></tr><tr><td align="left">&#x02003;55-52</td><td align="left">Tarassovi</td><td align="left">Tarassovi</td><td align="left"><italic>L. borgpetersenii</italic></td></tr><tr><td align="left">&#x02003;Nan 10</td><td align="left">Mini</td><td align="left">Mini</td><td align="left"><italic>L. borgpetersenii</italic></td></tr><tr><td align="left">&#x02003;L 105</td><td align="left">Manhao 2</td><td align="left">Manhao</td><td align="left"><italic>L. weilii</italic></td></tr><tr><td align="left">Isolates (n = 163)</td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;85</td><td align="left">Lai</td><td align="left">Icterohaemorrhagiae</td><td align="left"><italic>L. interrogans</italic></td></tr><tr><td align="left">&#x02003;5</td><td align="left">Canicola</td><td align="left">Canicola</td><td align="left"><italic>L. interrogans</italic></td></tr><tr><td align="left">&#x02003;4</td><td align="left">Autumnalis</td><td align="left">Autumnalis</td><td align="left"><italic>L. interrogans</italic></td></tr><tr><td align="left">&#x02003;18</td><td align="left">Pomona</td><td align="left">Pomona</td><td align="left"><italic>L. interrogans</italic></td></tr><tr><td align="left">&#x02003;11</td><td align="left">Grippotyphosa</td><td align="left">Grippotyphosa</td><td align="left"><italic>L. interrogans</italic></td></tr><tr><td align="left">&#x02003;15</td><td align="left">Hebdomadis</td><td align="left">Hebdomadis</td><td align="left"><italic>L. interrogans</italic></td></tr><tr><td align="left">&#x02003;20</td><td align="left">Medanesis</td><td align="left">Sejroe</td><td align="left"><italic>L. interrogans</italic></td></tr><tr><td align="left">&#x02003;5</td><td align="left">Australis</td><td align="left">Australis</td><td align="left"><italic>L. interrogans</italic></td></tr><tr><td align="left">Patient sera (n = 385)</td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;191</td><td align="left">Lai</td><td align="left">Icterohaemorrhagia</td><td align="left"><italic>L. interrogans</italic></td></tr><tr><td align="left">&#x02003;11</td><td align="left">Canicola</td><td align="left">Canicola</td><td align="left"><italic>L. interrogans</italic></td></tr><tr><td align="left">&#x02003;13</td><td align="left">Autumnalis</td><td align="left">Autumnalis</td><td align="left"><italic>L. interrogans</italic></td></tr><tr><td align="left">&#x02003;37</td><td align="left">Pomona</td><td align="left">Pomona</td><td align="left"><italic>L. noguchii</italic></td></tr><tr><td align="left">&#x02003;31</td><td align="left">Grippotyphosa</td><td align="left">Grippotyphosa</td><td align="left"><italic>L. interrogans</italic></td></tr><tr><td align="left">&#x02003;44</td><td align="left">Hebdomadis</td><td align="left">Hebdomadis</td><td align="left"><italic>L. interrogans</italic></td></tr><tr><td align="left">&#x02003;45</td><td align="left">Medanesis</td><td align="left">Sejroe</td><td align="left"><italic>L. interrogans</italic></td></tr><tr><td align="left">&#x02003;13</td><td align="left">Australis</td><td align="left">Australis</td><td align="left"><italic>L. interrogans</italic></td></tr><tr><td align="left">Normal sera (n = 36)</td><td align="left">/</td><td align="left">/</td><td align="left">/</td></tr></tbody></table></table-wrap></sec><sec><title>Molecular phylogeny and gene-typing of <italic>ompL1 </italic>gene</title><p>Based on the molecular phylogenetic relationship of their nucleotide sequences (GenBank Accession No.: <ext-link ext-link-type="gen" xlink:href="AY622658">AY622658</ext-link>&#x02013;<ext-link ext-link-type="gen" xlink:href="AY622672">AY622672</ext-link>) and putative amino acid sequences (Figure <xref ref-type="fig" rid="F1">1</xref>, see Additional file <xref ref-type="supplementary-material" rid="S1">1</xref> for details), o<italic>mpL1 </italic>genes from the pathogenic leptospires could be classified into three groups: <italic>ompL1/1</italic>, <italic>ompL1/2 </italic>and <italic>ompL1/3 </italic>(Table <xref ref-type="table" rid="T2">2</xref>). Sequence identity of the putative amino acid sequences between <italic>ompL1/1 </italic>and <italic>ompL1/2</italic>, <italic>ompL1/1 </italic>and <italic>ompL1/3</italic>, and <italic>ompL1/2 </italic>and <italic>ompL1/3 </italic>gene types was 92.50%&#x02013;93.44%, 85.31%&#x02013;86.88%, and 85.31%&#x02013;86.25%, respectively. In addition, the <italic>ompL1 </italic>gene sequencing data of 39 clinical strains also supported the classification into three groups (Table <xref ref-type="table" rid="T2">2</xref>). Both the nucleotide and putative amino acid sequence identities among the clinical strains with the same <italic>ompL1 </italic>gene type were above 98% (data not shown).</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p><italic>ompL1 </italic>gene types of standard strains and isolates of Leptospires</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Species</td><td align="left">Serogroup</td><td align="left">Serovar</td><td align="left">Strain (n)</td><td align="center" colspan="3"><italic>ompL1 </italic>gene type</td></tr><tr><td></td><td></td><td></td><td></td><td colspan="3"><hr></hr></td></tr><tr><td></td><td></td><td></td><td></td><td align="center">1</td><td align="center">2</td><td align="center">3</td></tr></thead><tbody><tr><td align="left"><italic>L. interrogans</italic></td><td align="left">Icterohaemorrhagiae</td><td align="left">Lai</td><td align="left">Lai</td><td></td><td align="center">&#x0221a;</td><td></td></tr><tr><td></td><td></td><td></td><td align="left">Wild (5)</td><td></td><td align="center">&#x0221a;</td><td></td></tr><tr><td align="left"><italic>L. interrogans</italic></td><td align="left">Canicola</td><td align="left">Canicola</td><td align="left">Lin</td><td></td><td align="center">&#x0221a;</td><td></td></tr><tr><td></td><td></td><td></td><td align="left">Wild (5)</td><td></td><td align="center">&#x0221a;</td><td></td></tr><tr><td align="left"><italic>L. interrogans</italic></td><td align="left">Australis</td><td align="left">Australis</td><td align="left">65-9</td><td></td><td align="center">&#x0221a;</td><td></td></tr><tr><td></td><td></td><td></td><td align="left">Wild (5)</td><td></td><td align="center">&#x0221a;</td><td></td></tr><tr><td align="left"><italic>L. interrogans</italic></td><td align="left">Pomona</td><td align="left">Pomona</td><td align="left">Luo</td><td></td><td align="center">&#x0221a;</td><td></td></tr><tr><td></td><td></td><td></td><td align="left">Wild (5)</td><td></td><td align="center">&#x0221a;</td><td></td></tr><tr><td align="left"><italic>L. interrogans</italic></td><td align="left">Hebdomadis</td><td align="left">Hebdomadis</td><td align="left">P 7</td><td></td><td align="center">&#x0221a;</td><td></td></tr><tr><td></td><td></td><td></td><td align="left">Wild (5)</td><td></td><td align="center">&#x0221a;</td><td></td></tr><tr><td align="left"><italic>L. interrogans</italic></td><td align="left">Autumnalis</td><td align="left">Autumnalis</td><td align="left">Lin 4</td><td align="center">&#x0221a;</td><td></td><td></td></tr><tr><td></td><td></td><td></td><td align="left">Wild (4)</td><td align="center">&#x0221a;</td><td></td><td></td></tr><tr><td align="left"><italic>L. interrogans</italic></td><td align="left">Grippotyphosa</td><td align="left">Grippotyphosa</td><td align="left">Lin 6</td><td align="center">&#x0221a;</td><td></td><td></td></tr><tr><td></td><td></td><td></td><td align="left">Wild (5)</td><td align="center">&#x0221a;</td><td></td><td></td></tr><tr><td align="left"><italic>L. interrogans</italic></td><td align="left">Sejroe</td><td align="left">Wolffi</td><td align="left">L 183</td><td align="center">&#x0221a;</td><td></td><td></td></tr><tr><td></td><td></td><td align="left">Medanesis</td><td align="left">Wild (5)</td><td align="center">&#x0221a;</td><td></td><td></td></tr><tr><td align="left"><italic>L. interrogans</italic></td><td align="left">Bataviae</td><td align="left">Paidjan</td><td align="left">L 37</td><td></td><td align="center">&#x0221a;</td><td></td></tr><tr><td align="left"><italic>L. interrogans</italic></td><td align="left">Pyrogenes</td><td align="left">Pyrogenes</td><td align="left">Tian</td><td></td><td></td><td align="center">&#x0221a;</td></tr><tr><td align="left"><italic>L. borgpetersenii</italic></td><td align="left">Javanica</td><td align="left">Javanica</td><td align="left">M 10</td><td></td><td></td><td align="center">&#x0221a;</td></tr><tr><td align="left"><italic>L. borgpetersenii</italic></td><td align="left">Ballum</td><td align="left">Ballum</td><td align="left">Pishu</td><td></td><td></td><td align="center">&#x0221a;</td></tr><tr><td align="left"><italic>L. borgpetersenii</italic></td><td align="left">Tarassovi</td><td align="left">Tarassovi</td><td align="left">55-52</td><td></td><td></td><td align="center">&#x0221a;</td></tr><tr><td align="left"><italic>L. borgpetersenii</italic></td><td align="left">Mini</td><td align="left">Mini</td><td align="left">Nan 10</td><td></td><td></td><td align="center">&#x0221a;</td></tr><tr><td align="left"><italic>L. weilii</italic></td><td align="left">Manhao</td><td align="left">Manhao II</td><td align="left">L 105</td><td></td><td align="center">&#x0221a;</td><td></td></tr></tbody></table></table-wrap><fig position="float" id="F1"><label>Figure 1</label><caption><p><bold>Maximum parsimony trees for <italic>ompL1 </italic>nucleotide sequences (A) and its amino acid sequences (B) of 15 standard strains</bold>. This figure shows the upper quartile, for the full image please see Additional file <xref ref-type="supplementary-material" rid="S1">1</xref>. The numbers at each fork node indicate the bootstrapping values (shown only when &#x0003e; 50%). RefSeq accession number and abbreviation for the organism are shown at each relevant branch. The scale bar indicates the number of character substitutions.</p></caption><graphic xlink:href="1471-2180-8-223-1"/></fig></sec><sec><title>Data of secondary structure analysis of OmpL1 proteins</title><p>All the three gene types of OmpL1 proteins had very similar predicted secondary structures and antigenic indexes (Figure <xref ref-type="fig" rid="F2">2</xref>, see Additional file <xref ref-type="supplementary-material" rid="S2">2</xref> for details). The OmpL1 proteins had five main putative surface-membrane regions (70&#x02013;80, 115&#x02013;120, 145&#x02013;150, 235&#x02013;245, 305&#x02013;310 amino acid residuals) and seven transmembrane regions (10&#x02013;40, 120&#x02013;130, 160&#x02013;190, 215&#x02013;225, 240&#x02013;250, 270&#x02013;280, and 295&#x02013;305 amino acid residues). The only salient different was the presence of less alpha-helix in the N-terminal and beta-sheet in the C-terminal region of the OmpL1/3 sequence, compared to the sequences of OmpL1/1 and OmpL1/2.</p><fig position="float" id="F2"><label>Figure 2</label><caption><p><bold>Comparison of the predicted secondary structures and antigenic index of OmpL1 proteins</bold>. This figure shows the upper quartile, for the full image please see Additional file <xref ref-type="supplementary-material" rid="S2">2</xref>. The related strains of the same gene type just show the same predicted structure topology. Thus, only the results from three representative strains are showed here.</p></caption><graphic xlink:href="1471-2180-8-223-2"/></fig></sec><sec><title>Identification of expressed rOmpL1 proteins and titers of rabbit antisera</title><p>rOmpL1/1, rOmpL1/2 and rOmpL1/3 were well expressed after induction with IPTG and showed single bands in gel after purification by Ni-NTA-chromatography (Figure <xref ref-type="fig" rid="F3">3</xref>). Western blot analysis also indicated that serum samples from leptospirosis patients could recognize rOmpL1 proteins (Figure <xref ref-type="fig" rid="F4">4</xref>), implying that the proteins are immunogenic during natural infection. Immunodiffusion titers of all the rabbit antisera against rOmpL1 proteins were at least 1:4.</p><fig position="float" id="F3"><label>Figure 3</label><caption><p><bold>Expression and purification of recombinant OmpL1 proteins</bold>. Lanes 1 and 6: protein markers (BioColor); lane 2: pET42a with no inserted <italic>ompL1 </italic>genes; lanes 3 to 5: the expressed rOmpL1/1, rOmpL1/2 and rOmpL1/3, respectively; lanes 7 to 9: the purified rOmpL1/1, rOmpL1/2 and rOmpL1/3, respectively.</p></caption><graphic xlink:href="1471-2180-8-223-3"/></fig><fig position="float" id="F4"><label>Figure 4</label><caption><p><bold>Recognition of purified rOmpL1 proteins by sera from leptospirosis patients</bold>. Lane 1: protein markers (BioColor); lanes 2&#x02013;13: the rOmpL1/1, rOmpL1/2 and rOmpL1/3 hybridizing with the antisera from leptospirosis patients; lane 13: normal human serum used as control.</p></caption><graphic xlink:href="1471-2180-8-223-4"/></fig></sec><sec><title>Localization of OmpL1 proteins on leptospires</title><p>Using anti-rOmpL1/1, anti-rOmpL1/2 and anti-rOmpL1/3 sera as the primary antibodies, all the colloidal gold particles conjugated to secondary antibodies were bound on the surface of <italic>L. interrogans </italic>serovar Autumnalis strain Lin 4 (<italic>ompL1/1 </italic>gene type), serovar Lai strain Lai (<italic>ompL1/2 </italic>gene type), and <italic>L. borgpetersenii </italic>serovar Ballum strain Pishu (<italic>ompL1/3 </italic>gene type) (Figure <xref ref-type="fig" rid="F5">5</xref>).</p><fig position="float" id="F5"><label>Figure 5</label><caption><p><bold>The localization of OmpL1 on the surface of leptospires</bold>. A: negative control; B to D: the immunogold particles binding to OmpL1/1, OmpL1/2 and OmpL1/3 on the surface of <italic>L. interrogans </italic>serovar Autumnalis strain Lin 4, serovar Lai strain Lai, and <italic>L. borgpetersenii </italic>serovars Ballum strain Pishu, respectively.</p></caption><graphic xlink:href="1471-2180-8-223-5"/></fig></sec><sec><title>Titers of MAT</title><p>The antisera against rOmpL1/1, rOmpL1/2 and rOmpL1/3 were able to cross-agglutinate with MAT titers of 1:100 to 1:800 for all the 15 standard strains and 163 clinical strains of pathogenic leptospires (Table <xref ref-type="table" rid="T3">3</xref>).</p><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>MAT titers among anti-rOmpL1 antisera and 178 leptospiral strains</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Strain</td><td align="left">Serovar</td><td align="center">Gene type</td><td align="center" colspan="3">MAT titer (1:xxx)</td></tr><tr><td></td><td></td><td></td><td colspan="3"><hr></hr></td></tr><tr><td></td><td></td><td></td><td align="center">Anti-OmpL1/1</td><td align="center">Anti-OmpL1/2</td><td align="center">Anti-OmpL1/3</td></tr></thead><tbody><tr><td align="left">Standards (n = 15)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;Lai</td><td align="left">Lai</td><td align="center">2</td><td align="center">400</td><td align="center">400</td><td align="center">200</td></tr><tr><td align="left">&#x02003;M 10</td><td align="left">Javanica</td><td align="center">3</td><td align="center">100</td><td align="center">100</td><td align="center">400</td></tr><tr><td align="left">&#x02003;Lin</td><td align="left">Canicola</td><td align="center">2</td><td align="center">200</td><td align="center">400</td><td align="center">100</td></tr><tr><td align="left">&#x02003;Pishu</td><td align="left">Ballum</td><td align="center">3</td><td align="center">100</td><td align="center">200</td><td align="center">400</td></tr><tr><td align="left">&#x02003;Tian</td><td align="left">Pyrogenes</td><td align="center">3</td><td align="center">100</td><td align="center">100</td><td align="center">400</td></tr><tr><td align="left">&#x02003;Lin 4</td><td align="left">Autumnalis</td><td align="center">1</td><td align="center">400</td><td align="center">400</td><td align="center">200</td></tr><tr><td align="left">&#x02003;65-9</td><td align="left">Australis</td><td align="center">2</td><td align="center">200</td><td align="center">400</td><td align="center">100</td></tr><tr><td align="left">&#x02003;Luo</td><td align="left">Pomona</td><td align="center">2</td><td align="center">200</td><td align="center">400</td><td align="center">100</td></tr><tr><td align="left">&#x02003;Lin 6</td><td align="left">Grippotyphosa</td><td align="center">1</td><td align="center">400</td><td align="center">400</td><td align="center">200</td></tr><tr><td align="left">&#x02003;P 7</td><td align="left">Hebdomadis</td><td align="center">2</td><td align="center">200</td><td align="center">400</td><td align="center">100</td></tr><tr><td align="left">&#x02003;L 37</td><td align="left">Paidjan</td><td align="center">2</td><td align="center">200</td><td align="center">400</td><td align="center">100</td></tr><tr><td align="left">&#x02003;55-52</td><td align="left">Tarassovi</td><td align="center">3</td><td align="center">100</td><td align="center">200</td><td align="center">400</td></tr><tr><td align="left">&#x02003;L 105</td><td align="left">Manhao II</td><td align="center">2</td><td align="center">200</td><td align="center">400</td><td align="center">100</td></tr><tr><td align="left">&#x02003;L 183</td><td align="left">Wolffi</td><td align="center">1</td><td align="center">400</td><td align="center">200</td><td align="center">100</td></tr><tr><td align="left">&#x02003;Nan 10</td><td align="left">Mini</td><td align="center">3</td><td align="center">100</td><td align="center">100</td><td align="center">200</td></tr><tr><td align="left">Isolates (n = 163)</td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">&#x02003;85</td><td align="left">Lai</td><td></td><td align="center">200~400</td><td align="center">200~800</td><td align="center">100~200</td></tr><tr><td align="left">&#x02003;5</td><td align="left">Canicola</td><td></td><td align="center">200</td><td align="center">400</td><td align="center">100</td></tr><tr><td align="left">&#x02003;4</td><td align="left">Autumnalis</td><td></td><td align="center">400</td><td align="center">200~400</td><td align="center">100</td></tr><tr><td align="left">&#x02003;5</td><td align="left">Australis</td><td></td><td align="center">200</td><td align="center">400</td><td align="center">100</td></tr><tr><td align="left">&#x02003;18</td><td align="left">Pomona</td><td></td><td align="center">200~400</td><td align="center">200~800</td><td align="center">100~200</td></tr><tr><td align="left">&#x02003;11</td><td align="left">Grippotyphosa</td><td></td><td align="center">400~800</td><td align="center">200~400</td><td align="center">100~200</td></tr><tr><td align="left">&#x02003;15</td><td align="left">Hebdomadis</td><td></td><td align="center">200~400</td><td align="center">200~800</td><td align="center">100~200</td></tr><tr><td align="left">&#x02003;20</td><td align="left">Medanesis</td><td></td><td align="center">400</td><td align="center">200~400</td><td align="center">100~200</td></tr></tbody></table></table-wrap></sec><sec><title>Detection of antibodies against rOmpL1 proteins in leptospirosis patients</title><p>In ELISA assays using rOmpL1/1, rOmpL1/2 and rOmpL1/3, the positive rates for IgG in specimens from 385 leptospirosis patients using 1:100 and 1:200 serum dilutions were 87.8% (338/385) and 78.2% (301/385), 95.1% (366/385) and 82.1% (316/385), and 77.7% (299/385) and 65.5% (252/385), respectively (Table <xref ref-type="table" rid="T4">4</xref>). When using 1:50 and 1:100 serum dilutions from the same specimens, the positive rates for IgM were 83.4% (321/385) and 72.7% (280/385), 87.0% (335/385) and 77.4% (298/385), and 74.3% (286/385) and 63.1% (243/385), respectively (Table <xref ref-type="table" rid="T4">4</xref>).</p><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>ELISA detection of rOmpL1-IgG/IgM in sera of leptospirosis patients</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="left">Sera</td><td align="center">Cases (n)</td><td align="center">Dilution (1:xxx)</td><td align="center" colspan="3">IgG-ELISA positive (n)</td><td align="center" colspan="3">IgM-ELISA positive (n)</td></tr><tr><td></td><td></td><td></td><td colspan="3"><hr></hr></td><td colspan="3"><hr></hr></td></tr><tr><td></td><td></td><td></td><td align="center">rOmpL1/1</td><td align="center">rOmpL1/2</td><td align="center">rOmpL1/3</td><td align="center">rOMPL1/1</td><td align="center">rOMPL1/2</td><td align="center">rOMPL1/3</td></tr></thead><tbody><tr><td align="left">Patients infected with:</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td align="left">Icterohaemorrhagia</td><td align="center">191</td><td align="center">50</td><td align="center">/</td><td align="center">/</td><td align="center">/</td><td align="center">145</td><td align="center">161</td><td align="center">139</td></tr><tr><td></td><td></td><td align="center">100</td><td align="center">159</td><td align="center">187</td><td align="center">149</td><td align="center">132</td><td align="center">152</td><td align="center">128</td></tr><tr><td></td><td></td><td align="center">200</td><td align="center">147</td><td align="center">162</td><td align="center">135</td><td align="center">/</td><td align="center">/</td><td align="center">/</td></tr><tr><td align="left">Canicola</td><td align="center">11</td><td align="center">50</td><td align="center">/</td><td align="center">/</td><td align="center">/</td><td align="center">9</td><td align="center">11</td><td align="center">9</td></tr><tr><td></td><td></td><td align="center">100</td><td align="center">10</td><td align="center">11</td><td align="center">9</td><td align="center">8</td><td align="center">9</td><td align="center">6</td></tr><tr><td></td><td></td><td align="center">200</td><td align="center">8</td><td align="center">10</td><td align="center">6</td><td align="center">/</td><td align="center">/</td><td align="center">/</td></tr><tr><td align="left">Autumnalis</td><td align="center">13</td><td align="center">50</td><td align="center">/</td><td align="center">/</td><td align="center">/</td><td align="center">13</td><td align="center">11</td><td align="center">9</td></tr><tr><td></td><td></td><td align="center">100</td><td align="center">13</td><td align="center">12</td><td align="center">10</td><td align="center">10</td><td align="center">8</td><td align="center">7</td></tr><tr><td></td><td></td><td align="center">200</td><td align="center">12</td><td align="center">9</td><td align="center">7</td><td align="center">/</td><td align="center">/</td><td align="center">/</td></tr><tr><td align="left">Pomona</td><td align="center">44</td><td align="center">50</td><td align="center">/</td><td align="center">/</td><td align="center">/</td><td align="center">38</td><td align="center">41</td><td align="center">31</td></tr><tr><td></td><td></td><td align="center">100</td><td align="center">38</td><td align="center">43</td><td align="center">33</td><td align="center">31</td><td align="center">35</td><td align="center">26</td></tr><tr><td></td><td></td><td align="center">200</td><td align="center">33</td><td align="center">37</td><td align="center">27</td><td align="center">/</td><td align="center">/</td><td align="center">/</td></tr><tr><td align="left">Australis</td><td align="center">13</td><td align="center">50</td><td align="center">/</td><td align="center">/</td><td align="center">/</td><td align="center">12</td><td align="center">13</td><td align="center">10</td></tr><tr><td></td><td></td><td align="center">100</td><td align="center">12</td><td align="center">13</td><td align="center">10</td><td align="center">10</td><td align="center">11</td><td align="center">7</td></tr><tr><td></td><td></td><td align="center">200</td><td align="center">10</td><td align="center">11</td><td align="center">8</td><td align="center">/</td><td align="center">/</td><td align="center">/</td></tr><tr><td align="left">Grippotyphosa</td><td align="center">31</td><td align="center">50</td><td align="center">/</td><td align="center">/</td><td align="center">/</td><td align="center">29</td><td align="center">26</td><td align="center">22</td></tr><tr><td></td><td></td><td align="center">100</td><td align="center">30</td><td align="center">26</td><td align="center">23</td><td align="center">23</td><td align="center">21</td><td align="center">16</td></tr><tr><td></td><td></td><td align="center">200</td><td align="center">26</td><td align="center">23</td><td align="center">16</td><td align="center">/</td><td align="center">/</td><td align="center">/</td></tr><tr><td align="left">Hebdomadis</td><td align="center">37</td><td align="center">50</td><td align="center">/</td><td align="center">/</td><td align="center">/</td><td align="center">34</td><td align="center">35</td><td align="center">30</td></tr><tr><td></td><td></td><td align="center">100</td><td align="center">33</td><td align="center">36</td><td align="center">30</td><td align="center">29</td><td align="center">30</td><td align="center">25</td></tr><tr><td></td><td></td><td align="center">200</td><td align="center">28</td><td align="center">31</td><td align="center">24</td><td align="center">/</td><td align="center">/</td><td align="center">/</td></tr><tr><td align="left">Sejroe</td><td align="center">45</td><td align="center">50</td><td align="center">/</td><td align="center">/</td><td align="center">/</td><td align="center">41</td><td align="center">37</td><td align="center">36</td></tr><tr><td></td><td></td><td align="center">100</td><td align="center">43</td><td align="center">38</td><td align="center">35</td><td align="center">37</td><td align="center">32</td><td align="center">28</td></tr><tr><td></td><td></td><td align="center">200</td><td align="center">37</td><td align="center">33</td><td align="center">29</td><td align="center">/</td><td align="center">/</td><td align="center">/</td></tr><tr><td align="left">Total</td><td align="center">385</td><td align="center">50</td><td align="center">/</td><td align="center">/</td><td align="center">/</td><td align="center">321</td><td align="center">335</td><td align="center">286</td></tr><tr><td></td><td></td><td align="center">100</td><td align="center">338</td><td align="center">366</td><td align="center">299</td><td align="center">280</td><td align="center">298</td><td align="center">243</td></tr><tr><td></td><td></td><td align="center">200</td><td align="center">301</td><td align="center">316</td><td align="center">252</td><td align="center">/</td><td align="center">/</td><td align="center">/</td></tr><tr><td align="left">Healthy individuals:</td><td align="center">36</td><td align="center">50</td><td align="center">/</td><td align="center">/</td><td align="center">/</td><td align="center">0.20 &#x000b1; 0.06</td><td align="center">0.20 &#x000b1; 0.07</td><td align="center">0.19 &#x000b1; 0.07</td></tr><tr><td></td><td></td><td align="center">Cut-off</td><td align="center">/</td><td align="center">/</td><td align="center">/</td><td align="center">0.38</td><td align="center">0.41</td><td align="center">0.40</td></tr><tr><td></td><td></td><td align="center">100</td><td align="center">0.17 &#x000b1; 0.05</td><td align="center">0.18 &#x000b1; 0.05</td><td align="center">0.17 &#x000b1; 0.06</td><td align="center">0.18 &#x000b1; 0.05</td><td align="center">0.17 &#x000b1; 0.06</td><td align="center">0.17 &#x000b1; 0.05</td></tr><tr><td></td><td></td><td align="center">Cut-off</td><td align="center">0.32</td><td align="center">0.33</td><td align="center">0.35</td><td align="center">0.33</td><td align="center">0.35</td><td align="center">0.32</td></tr><tr><td></td><td></td><td align="center">200</td><td align="center">0.14 &#x000b1; 0.04</td><td align="center">0.13 &#x000b1; 0.05</td><td align="center">0.15 &#x000b1; 0.04</td><td align="center">/</td><td align="center">/</td><td align="center">/</td></tr><tr><td></td><td></td><td align="center">Cut-off</td><td align="center">0.26</td><td align="center">0.28</td><td align="center">0.27</td><td align="center">/</td><td align="center">/</td><td align="center">/</td></tr></tbody></table><table-wrap-foot><p>Note: the mean at OD<sub>490 </sub>+ 3 SD = cut-off value</p></table-wrap-foot></table-wrap></sec><sec><title>Inhibition of adherence by antisera against rOmpL1 proteins</title><p>Anti-rOmpL1/1 (1:200 dilution), anti-rOmpL1/2 (1:300 dilution) or anti-rOmpL1/3 (1:50 dilution) sera could completely inhibit the adherence of <italic>L. interrogans </italic>serovar Lai strain Lai to macrophages (Figure <xref ref-type="fig" rid="F6">6</xref>), demonstrating cross-inhibition effects among the different anti-sera.</p><fig position="float" id="F6"><label>Figure 6</label><caption><p><bold>Inhibition of leptospiral adherence to J744A.1 macrophages in the presence anti-rOmpL1 antiserum</bold>. A: Leptospires binding to macrophages in the presence of irrelevant antisera. B: inhibition of leptospiral binding to macrophages in the presence of antiserum against recombinant OmpL1 protein (amplification &#x000d7;1000).</p></caption><graphic xlink:href="1471-2180-8-223-6"/></fig></sec><sec><title>Immunoprotection due to immunization with rOmpL1 proteins</title><p>Immunization of guinea pigs with rOmpL1/1, rOmpL1/2 and rOmpL1/3 conferred a significant level of resistance against lethal challenge with pathogenic leptospires from the three different <italic>ompL1 </italic>groups (Table <xref ref-type="table" rid="T5">5</xref>). However, the immunoprotective rates against the same <italic>ompL1 </italic>gene type leptospiral infection as the immunizing recombinant protein (62.5%&#x02013;87.5%) were higher than when strains and proteins from different <italic>ompL1 </italic>gene types were used (25.0%&#x02013;62.5%).</p><table-wrap position="float" id="T5"><label>Table 5</label><caption><p>Immunoprotective effects of rOmpL1 proteins in guinea pigs</p></caption><table frame="hsides" rules="groups"><thead><tr><td align="center">Group</td><td align="center">Animals (n)</td><td align="center" colspan="3">Immunizing dosage (mg/kg)</td><td align="center">Infecting Leptospiral</td><td align="center">Survival/Death</td><td align="center">Protective rate</td></tr><tr><td></td><td></td><td colspan="3"><hr></hr></td><td></td><td></td><td></td></tr><tr><td></td><td></td><td align="center">rOmpL1/1</td><td align="center">rOmpL1/2</td><td align="center">rOmpL/3</td><td align="center">strain</td><td align="center">(n/n)</td><td align="center">(%)</td></tr></thead><tbody><tr><td align="center">A1</td><td align="center">8</td><td align="center">1.0</td><td align="center">/</td><td align="center">/</td><td align="center">Lai</td><td align="center">3/5</td><td align="center">37.5</td></tr><tr><td align="center">A2</td><td align="center">8</td><td align="center">2.0</td><td align="center">/</td><td align="center">/</td><td align="center">Lai</td><td align="center">5/3</td><td align="center">62.5</td></tr><tr><td align="center">A3</td><td align="center">8</td><td align="center">1.0</td><td align="center">/</td><td align="center">/</td><td align="center">Lin 4</td><td align="center">5/3</td><td align="center">62.5</td></tr><tr><td align="center">A4</td><td align="center">8</td><td align="center">2.0</td><td align="center">/</td><td align="center">/</td><td align="center">Lin 4</td><td align="center">7/1</td><td align="center">87.5</td></tr><tr><td align="center">A5</td><td align="center">8</td><td align="center">1.0</td><td align="center">/</td><td align="center">/</td><td align="center">Pishu</td><td align="center">2/6</td><td align="center">25.0</td></tr><tr><td align="center">A6</td><td align="center">8</td><td align="center">2.0</td><td align="center">/</td><td align="center">/</td><td align="center">Pishu</td><td align="center">3/5</td><td align="center">37.5</td></tr><tr><td align="center">B1</td><td align="center">8</td><td align="center">/</td><td align="center">1.0</td><td align="center">/</td><td align="center">Lai</td><td align="center">5/3</td><td align="center">62.5</td></tr><tr><td align="center">B2</td><td align="center">8</td><td align="center">/</td><td align="center">2.0</td><td align="center">/</td><td align="center">Lai</td><td align="center">6/2</td><td align="center">75.0</td></tr><tr><td align="center">B3</td><td align="center">8</td><td align="center">/</td><td align="center">1.0</td><td align="center">/</td><td align="center">Lin 4</td><td align="center">4/4</td><td align="center">50.0</td></tr><tr><td align="center">B4</td><td align="center">8</td><td align="center">/</td><td align="center">2.0</td><td align="center">/</td><td align="center">Lin 4</td><td align="center">5/3</td><td align="center">62.5</td></tr><tr><td align="center">B5</td><td align="center">8</td><td align="center">/</td><td align="center">1.0</td><td align="center">/</td><td align="center">Pishu</td><td align="center">2/6</td><td align="center">25.0</td></tr><tr><td align="center">B6</td><td align="center">8</td><td align="center">/</td><td align="center">2.0</td><td align="center">/</td><td align="center">Pishu</td><td align="center">3/5</td><td align="center">37.5</td></tr><tr><td align="center">C1</td><td align="center">8</td><td align="center">/</td><td align="center">/</td><td align="center">1.0</td><td align="center">Lai</td><td align="center">2/6</td><td align="center">25.0</td></tr><tr><td align="center">C2</td><td align="center">8</td><td align="center">/</td><td align="center">/</td><td align="center">2.0</td><td align="center">Lai</td><td align="center">3/5</td><td align="center">37.5</td></tr><tr><td align="center">C3</td><td align="center">8</td><td align="center">/</td><td align="center">/</td><td align="center">1.0</td><td align="center">Lin 4</td><td align="center">3/5</td><td align="center">37.5</td></tr><tr><td align="center">C4</td><td align="center">8</td><td align="center">/</td><td align="center">/</td><td align="center">2.0</td><td align="center">Lin 4</td><td align="center">4/4</td><td align="center">50.0</td></tr><tr><td align="center">C5</td><td align="center">8</td><td align="center">/</td><td align="center">/</td><td align="center">1.0</td><td align="center">Pishu</td><td align="center">5/3</td><td align="center">62.5</td></tr><tr><td align="center">C6</td><td align="center">8</td><td align="center">/</td><td align="center">/</td><td align="center">2.0</td><td align="center">Pishu</td><td align="center">6/2</td><td align="center">75.0</td></tr><tr><td align="center">D1</td><td align="center">8</td><td align="center">/</td><td align="center">/</td><td align="center">/</td><td align="center">Lai</td><td align="center">0/8</td><td align="center">/</td></tr><tr><td align="center">D2</td><td align="center">8</td><td align="center">/</td><td align="center">/</td><td align="center">/</td><td align="center">Lin 4</td><td align="center">0/8</td><td align="center">/</td></tr><tr><td align="center">D3</td><td align="center">8</td><td align="center">/</td><td align="center">/</td><td align="center">/</td><td align="center">Pishu</td><td align="center">0/8</td><td align="center">/</td></tr></tbody></table></table-wrap></sec></sec><sec><title>Discussion</title><p>Outer membrane proteins exposed on the surface of leptospires are known to react with the host cell and environment. Interestingly, lipopolysaccharide fractions confer protective immunity against challenge with homologous but not heterogonous leptospires, whereas protein extract induced significant protection against both types of challenge [<xref ref-type="bibr" rid="B20">20</xref>]. Thus far, a number of outer membrane proteins of leptospires, such as OmpL1, LipL32, LipL36, LipL41, LigA and LigB, have been cloned and characterized, and some of them have been shown to stimulate specific immunity in animal models [<xref ref-type="bibr" rid="B21">21</xref>-<xref ref-type="bibr" rid="B24">24</xref>]. Among all the leptospiral Omps, OmpL1 is a unique transmembrane protein that was confirmed to function as a porin, contribute to the survival of leptospires, and display synergetic immunoprotection with LipL41 [<xref ref-type="bibr" rid="B16">16</xref>-<xref ref-type="bibr" rid="B18">18</xref>]. However, major questions such as the distribution of <italic>ompL1 </italic>gene types in leptospiral strains, the exact localization of OmpL1, and cross-immunogenicity and immunoprotective effects of OmpL1 proteins remain unaddressed.</p><p>This study reveals that the <italic>ompL1 </italic>gene is present in the genomes of all the pathogenic leptospires tested. According to our alignment and phylogenetic analysis from the 15 standard strains of pathogenic <italic>Leptospira </italic>spp., three groups of <italic>ompL1 </italic>(<italic>ompL1/1</italic>, <italic>ompL1/2 and ompl/3</italic>) exist. However, the predicted secondary structure of the OmpL1 proteins revealed that there is little difference among the three groups. Thus, the differences in nucleotide sequences in the <italic>ompL1 </italic>gene types may not affect the immunogenicity and OmpL1 proteins, identifying OmpL1 as a genus-specific protein antigen.</p><p>Surface exposure is a key characteristic for an effective antigen. Although OmpL1 may be an outer membrane protein according to previous reports, the precise localization of OmpL1 still remained unclear. Leptospires possess both inner and outer membranes, but only the proteins expressed in the outer membrane are capable of interacting with the host immune system. To begin to characterize the localization, we used the prokaryotic recombinant expression technique to obtain a large amount of homogeneous OmpL1 proteins for preparation of immunoresponsive antisera from rabbits. Visualization by immuno-electron microscopy using anti-OmpL1 anti-sera confirmed that OmpL1 is located at the surface of the outer membrane of leptospires. MAT is a standard method for serodiagnosis of leptospirosis and serological classification of leptospires, for which live leptospiral cells are typically used [<xref ref-type="bibr" rid="B23">23</xref>]. In this study, we used MAT to examine cross-immunoagglutination among the antisera from rOmpL1 proteins and a large number of strains belonging to different pathogenic leptospiral serogroups/serovars. The results indicated that there is extensive cross-immunoagglutination between the different <italic>ompL1 </italic>gene types of pathogenic leptospiral strains and the OmpL1 antisera, and not surprisingly, the highest agglutination was observed between antisera from the same <italic>ompL1 </italic>gene types as the leptospiral strains. Furthermore, ELISA results revealed that OmpL1s-specific antibodies are produced in all the sera from leptospirosis patients, and the trends in cross-immunoreactivities in the different ELISA tests are also similar to those of MAT.</p><p>At least 75 serovars of pathogenic leptospires belonging to 18 serogroups have been found to date in China, but only a few of them frequently cause leptospirosis. According to the annual reports on leptospirosis from Chinese CDCs, <italic>L. interrogans </italic>serogroup Icterohaemorrhagiae serovar Lai is the most dominant pathogenic leptospires, responsible for approximately 75% of the morbidity in the country. The other pathogenic leptospires causing leptospirosis are the Grippotyphosa, Autumnalis, Australis, Pomona and Hebdomadis serovars [<xref ref-type="bibr" rid="B3">3</xref>,<xref ref-type="bibr" rid="B11">11</xref>,<xref ref-type="bibr" rid="B25">25</xref>]. Our study showed that all the 163 clinical strains of different pathogenic Leptospiral serogroup/serovars belong to either the <italic>ompL1/1 </italic>or <italic>ompL1/2 </italic>group (data not shown). Thus, we conclude that leptospires from the <italic>ompL1/1 </italic>and <italic>ompL1/2 </italic>groups are the most prevalent strains in China.</p><p>In this study, immunization with either rOmpL1/1, rOmpL1/2 or rOmpL1/3 proteins could enhance significantly survival of guinea pigs lethally challenged with pathogenic <italic>Leptospira </italic>species (Table <xref ref-type="table" rid="T5">5</xref>). The immunoprotective rates in the groups, in which animals received a rOmpL1 for immunization and challenge with the same <italic>ompL1 </italic>gene type, appeared to be higher than those being challenged with different <italic>ompL1 </italic>gene types.</p><p>In a previous study [<xref ref-type="bibr" rid="B35">35</xref>], we found <italic>L. interrogans </italic>serovar Lai strain Lai could adhere to macrophages, and we here show that adherence to macrophages could be blocked with antisera against any of the rOmpL1 proteins, confirming cross-immunogenicity of OmpL1 proteins from the three different groups. All these data collectively suggest that OmpL1 is likely a genus-specific antigen.</p></sec><sec><title>Conclusion</title><p>OmpL1 is a transmembrane protein extensively expressed in pathogenic leptospires. Although the <italic>ompL1 </italic>gene can belong to any of three different gene types, the OmpL1 proteins expressed by different gene types have conserved immunogenicity and the specific antibodies generally exist in sera of leptospirosis patients. OmpL1 should thus be viewed as a potential candidate of genus-specific antigen for the development of new universal vaccines and serodiagnostic methods for leptospirosis.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Leptospiral strains and serum specimens</title><p>The National Institute for the Control of Pharmaceutical and Biological Products (NICPBP) in Beijing, China, provided all 15 official Chinese standard strains belonging to fifteen different pathogenic serogroups of <italic>Leptospira</italic>. In addition, 163 clinical pathogenic Leptospiral isolates and 385 serum specimens from leptospirosis patients with MAT titers of &#x02265; 1:100 were provided by the Centers of Disease Prevention and Control of Sichuan, Anhui and Zhejiang provinces in China during 2004&#x02013;2007 (Table <xref ref-type="table" rid="T1">1</xref>). All the leptospiral strains were cultured in liquid Korthof medium containing 8% rabbit serum at 28&#x000b0;C [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B25">25</xref>]. All the patients were clinically diagnosed suffering from acute leptospirosis based on their medical history and clinical symptoms, including fevers, jaundice, hemorrhaging, myalgia and lymphadenectasis, as well as laboratory examination. Finally, 36 sera samples with negative results by MAT from healthy individuals for routine somatoscopy were offered by the First Affiliated Hospital of Zhejiang University. Informed written consent for sample collection was obtained from all participants and individuals with ethical approval from the Ethics Committee of Zhejiang University. This research was conducted in accordance with the Declaration of Helsinki and with the Guide for Care and Use of Laboratory Animals as adopted and promulgated by the United States National Institutes of Health. All experimental protocols were approved by the Ethics Committee of Zhejiang University.</p></sec><sec><title>Cell line and cell culture</title><p>The murine monocyte/macrophage-like cell line, J774A.1, was provided by the Cell Bank of the Institute of Cell Biology in Shanghai, Chinese Academy of Science, and was maintained in RPMI 1640 medium (GiBco, Grand Island, USA) supplemented with 10% fetal bovine serum (FBS) (GiBco), and 100 U/ml penicillin and 100 &#x003bc;g/ml streptomycin. The cells were cultured in 5% CO<sub>2 </sub>at 37&#x000b0;C.</p></sec><sec><title>Amplification and sequencing of <italic>ompL1 </italic>genes</title><p>Leptospiral DNA was extracted using Bacterial Genomic DNA Extraction Kit (BioColor BioScience &#x00026; Technology Co., Shanghai, China) and then dissolved in TE buffer. Density and purity of the extracted DNAs were detected by UV spectrophotometery. One pair of primers was applied to amplify the entire <italic>ompL1 </italic>gene. The upstream primer was 5'-CCG <underline>CATATG</underline> (Nde I) ATC CGT AAC ATA AGT AAG-3' and the downstream primer was 5'-CCG <underline>CTCGAG</underline> (Xho I) GAG TTC GTG TTT ATA ACC-3'. A High Fidelity PCR Kit (TaKaRa, Dalian, China), in which Taq-Pfu mixture is used as DNA polymerase, was used to amplify the target gene. The total volume per PCR was 50 &#x003bc;l which included 20 pmol of each of the primers, 2.5 U Taq-Pfu DNA polymerase, and 100 ng DNA templates. The reaction mixture was initiated by incubation at 94&#x000b0;C for 5 min, followed by 30 cycles of amplification at 94&#x000b0;C for 30 s, 55&#x000b0;C for 30 s and 72&#x000b0;C for 90 s, and then incubation at 72&#x000b0;C for 10 min. The products were detected in 1.5% ethidium bromide pre-stained agarose gel by agarose electrophoresis. The target products were predicted to be 960 base pairs (bp) in size. To obtain more accurate sequence data, the PCR products were purified using PCR Products Purification Kit (BioColor) and then ligated into plasmid pMD 18-T using T-A Cloning Kit (TaKaRa) [<xref ref-type="bibr" rid="B26">26</xref>]. The cloned <italic>ompL1 </italic>genes of 15 standard strains and 39 clinical strains were sequenced by Invitrogen (Shanghai, China).</p></sec><sec><title>Phylogenetic analysis and secondary structure prediction of OmpL1 protein</title><p>The similarity and homology of sequences were first evaluated with the BLASTN program of NCBI. Alignments were carried out using ClustalX 1.83 software [<xref ref-type="bibr" rid="B27">27</xref>] and manually adjusted using GeneDoc 2.7 software. The amino acid sequences were deduced from their nucleotide sequences. Phylogenetic analysis was carried out with Maximum Parsimony (MP) and Maximum Likelihood (ML) optimality criteria of the PAUP* package (Version 4.0b10) [<xref ref-type="bibr" rid="B28">28</xref>] and MEGA 3.1 software [<xref ref-type="bibr" rid="B29">29</xref>]. And the probability prediction for secondary structures [<xref ref-type="bibr" rid="B30">30</xref>,<xref ref-type="bibr" rid="B31">31</xref>], including antigenic analysis [<xref ref-type="bibr" rid="B32">32</xref>] of OmpL1 proteins, was computed using the protean program in DNAStar&#x02122; software package.</p></sec><sec><title>Prokaryotic expression and preparation of antisera against OmpL1 proteins</title><p>The recombinant plasmids <italic>pMD18-T-ompL1/1/2/3 </italic>as well as vector pET42a (Novagen, USA) were respectively digested with Nde I and Xho I (TaKaRa). The recovered <italic>ompL1 </italic>segments were respectively linked with the linearized pET42a by T4 DNA ligase (TaKaRa) and then transformed into <italic>E. coli </italic>BL21DE3 (Novagen). The three constructed prokaryotic expression systems were induced with 0.5 mM IPTG in LB medium to express recombinant OmpL1 (rOmpL1). Expression of rOmpL1 was examined by SDS-PAGE plus Gel Image Analyzor (BioRad, USA). The expressed rOmpL1 proteins were extracted and purified by Ni-NTA affinity chromatography. New Zealand white Rabbits provided by the Laboratory Animal Center, Zhejiang University, were immunized intradermally with each of the purified rOmpL1 proteins pre-mixed with Freund's adjuvant for four times at an interval of once a week. On the 15th day after the last immunization, the rabbit sera were collected and the Immunodiffusion test was used to examine the titers of antisera [<xref ref-type="bibr" rid="B24">24</xref>].</p></sec><sec><title>Western blot assay</title><p>Western blot analysis was used to identify the immunoreactivity of rOmpL1 proteins using 12 serum samples from the patients diluted at 1:1000 (the same dilution of normal human sera was used as control) as the primary antibodies, and 1:3000 diluted HRP-labeled goat anti-human IgG (Jackson ImmunoResearch Laboratories Inc., USA) as the secondary antibody.</p></sec><sec><title>Immuno-electron microscopy</title><p>Freshly-cultured <italic>L. interrogans </italic>serovar Autumnalis strain Lin 4 (<italic>ompL1/1 </italic>gene type), serovar Lai strain Lai (<italic>ompL1/2 </italic>gene type), and <italic>L. borgpetersenii </italic>serovar Ballum strain Pishu (<italic>ompL1/3 </italic>gene type) were centrifuged at 12, 000 rpm for 15 min at 15&#x000b0;C. The precipitates were fixed with fresh 2% paraformaldehyde at 4&#x000b0;C for 24 h. Prepared sections were exposed to 5% FBS at room temperature for 30 min to block unspecific antigens, and then incubated with each 1:1000 diluted rOmpL1s rabbit antisera or preimmune normal rabbit sera (negative control) as the first antibody and 1:2000 diluted colloidal gold (12 nm)-labeled goat anti-rabbit IgG (Jackson ImmunoResearch Laboratories) as the second antibody. The locations of OmpL1s were determined under transmission electron microscope (Philips TECNAL-10, Eindhoven, Holland)[<xref ref-type="bibr" rid="B16">16</xref>].</p></sec><sec><title>Microscopic agglutination test</title><p>The microscopic agglutination test (MAT) was used to determine cross-immunoagglutination under dark-field microscopy using rabbit antisera against the rOmpL1 proteins reacting with the 15 freshly-cultured standard strains and 163 clinical isolates of leptospires, in which normal saline was used as negative control [<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B33">33</xref>].</p></sec><sec><title>ELISA assay with rOmpL1 proteins</title><p>Enzyme-linked immunosorbent assays (ELISAs) were used to detect rOmpL1/1 or rOmpL1/2-specific IgM or IgG. Briefly, 96-well plates were coated with 50 &#x003bc;g/ml rOmpL1/1 or rOmpL1/2 (100 &#x003bc;l per well) at 4&#x000b0;C overnight, and then incubated with 5% FBS for 30 min to block unspecific binding. Using the diluted serum specimens from patients or normal individuals (1:50 or 1:100 dilution for IgM detection, and 1:100 or 1:200 dilution for IgG detection) as the primary antibody, HRP-labeling goat anti-human IgM (1:3000 dilution) or IgG (1:4000 dilution) (Jackson ImmunoResearch Laboratories) as the secondary antibody, and o-phenvlenediamine (OPD) as the substrate, the rOmpL1 proteins-specific IgM or IgG were examined under a Microplate Reader (Model 550, BioRad). OD<sub>490 </sub>values over the mean plus 3 SD of the 36 normal serum specimens were defined as positive [<xref ref-type="bibr" rid="B34">34</xref>].</p></sec><sec><title>Adherence inhibition test</title><p>J774A.1 cells (1 &#x000d7; 10<sup>5 </sup>cells in 1 ml medium per well) were inoculated in 12-well plates (Corning, USA) containing glass cover slips, incubated at 37&#x000b0;C for 24 h. Freshly-grown cultures of <italic>L. interrogans </italic>serovar Lai strain Lai were centrifuged at 10,000 rpm for 15 min at 15&#x000b0;C, and the precipitates were then suspended in antibiotics-free RPMI 1640 medium (GiBco) to a final concentration of 10<sup>8</sup>/ml. The antisera against rOmpL1 proteins were serially double-diluted with antibiotics-free RPMI 1640 medium (1:2 to 1:32), then mixed with the same volumes of each leptospiral suspension. The mixtures were incubated at 37&#x000b0;C for 1 h. The medium in the 12-well plates was removed, and then the plates were repeatedly washed with antibiotic-free RPMI1640 medium. The mixtures were added into the plates to incubate at 37&#x000b0;C for 1 h. After the incubation, the plates were repeatedly washed with PBS to remove non-adhered leptospires, and the Fontana silver-stained leptospires adhering J774A.1 cells were observed under light microscope [<xref ref-type="bibr" rid="B35">35</xref>]. In this test, preimmune rabbit serum instead of the antisera was used as control.</p></sec><sec><title>Immunoprotective test in guinea pigs</title><p>Dunkin-Hartley guinea pigs (150 &#x000b1; 5 g, 3 weeks old) used in this study were provided by Laboratory Animal Center of Zhejiang University (certificate no. SCXK [zhe]2007-0030). <italic>L. interrogans </italic>serovar Lai strain Lai, serovar Autumnalis strain Lin 4, and <italic>L. borgpetersenii </italic>serovar Bullum stain Pishu were maintained by serial passage in guinea pigs for preservation of virulence before use for challenge. Eighteen groups of guinea pigs (A1&#x02013;6, B1&#x02013;6, and C1&#x02013;C6) were subcutaneously immunized twice at an interval of once a week with different dosages of rOmpL1/1, rOmpL1/2 and rOmpL1/3, respectively. In addition, another three groups of guinea pigs (D1-3) were immunized with bovine serum albumin (BSA) (Sigma, USA) as control. Each protein antigen was pre-mixed with 0.7 mg aluminum hydroxide (Sigma) [<xref ref-type="bibr" rid="B36">36</xref>]. On the 15th day after the last immunization, the animals were challenged intraperitoneally with lethal doses of strain Lai, strain Lin 4 or strain Pishu and then observed for another 7 days.</p></sec></sec><sec><title>Authors' contributions</title><p>HD carried out the molecular genetic studies, immunoassays, drafted the manuscript. YH: carried out the immunoelectron microscope assay. FX carried out the bioinformatics analysis and immunoprotective test. JM carried out the immunoassays, cultured the leptospires. DS participated in the design of the study, analysis and interpretation of data. DO participated in study design and coordination, revised the manuscript. JY conceived of the study, and participated in its design and coordination. All authors read and approved the final manuscript, agreed to be published.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="S1"><caption><title>Additional file 1</title><p><bold>Full image of maximum parsimony trees for <italic>ompL1 </italic>nucleotide sequences (A) and its amino acid sequences (B) of 15 standard strains.</bold> This figure showed the phylogenetic relationship of nucleotide sequence and amino acid sequences of Chinese 15 standard strains of pathogenic leptospires.</p></caption><media xlink:href="1471-2180-8-223-S1.tiff" mimetype="image" mime-subtype="tiff"><caption><p>Click here for file</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="S2"><caption><title>Additional file 2</title><p><bold>Full image of comparison of the predicted secondary structures and antigenic index of OmpL1 proteins.</bold> This figure showed the predicted secondary structures and antigenic index of OmpL1 proteins belongs to three gene types (<italic>ompL1/1, ompL1/2, and ompL1/3</italic>).</p></caption><media xlink:href="1471-2180-8-223-S2.tiff" mimetype="image" mime-subtype="tiff"><caption><p>Click here for file</p></caption></media></supplementary-material></sec></body><back><ack><sec><title>Acknowledgements</title><p>This work was supported by Key Science and Technique Plan project of Zhejiang Province, China (Grant No. 2006C24003) and National science and technology Key program of China (Grant No. 2008ZX10404). We thank the CDCs of China for providing the clinical strains of pathogenic leptospires and serum specimens from leptospirosis patients.</p></sec></ack><ref-list><ref id="B1"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Levett</surname><given-names>PN</given-names></name></person-group><article-title>Leptospirosis</article-title><source>Clin Microbiol Rev</source><year>2001</year><volume>14</volume><fpage>296</fpage><lpage>326</lpage><pub-id pub-id-type="pmid">11292640</pub-id><pub-id pub-id-type="doi">10.1128/CMR.14.2.296-326.2001</pub-id></citation></ref><ref id="B2"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Faine</surname><given-names>S</given-names></name><name><surname>Adher</surname><given-names>B</given-names></name><name><surname>Bloin</surname><given-names>C</given-names></name><name><surname>Perolat</surname><given-names>P</given-names></name></person-group><source>Leptospira and leptospirosis</source><year>1999</year><edition>2</edition><publisher-name>Melbourne, Australia: MedSci</publisher-name></citation></ref><ref id="B3"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McBride</surname><given-names>AJ</given-names></name><name><surname>Athanazio</surname><given-names>DA</given-names></name><name><surname>Reis</surname><given-names>MG</given-names></name><name><surname>Ko</surname><given-names>AI</given-names></name></person-group><article-title>Leptospirosis</article-title><source>Curr Opin Infect Dis</source><year>2005</year><volume>18</volume><fpage>376</fpage><lpage>386</lpage><pub-id pub-id-type="pmid">16148523</pub-id><pub-id pub-id-type="doi">10.1097/01.qco.0000178824.05715.2c</pub-id></citation></ref><ref id="B4"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bharti</surname><given-names>AR</given-names></name><name><surname>Nally</surname><given-names>JE</given-names></name><name><surname>Ricaldi</surname><given-names>JN</given-names></name><name><surname>Matthias</surname><given-names>MA</given-names></name><name><surname>Diaz</surname><given-names>MM</given-names></name><name><surname>Lovett</surname><given-names>MA</given-names></name><name><surname>Levett</surname><given-names>PN</given-names></name><name><surname>Gilman</surname><given-names>RH</given-names></name><name><surname>Willig</surname><given-names>MR</given-names></name><name><surname>Gotuzzo</surname><given-names>E</given-names></name><name><surname>Vinetz</surname><given-names>JM</given-names></name><collab>Peru-United States Leptospirosis Consortium</collab></person-group><article-title>Leptospirosis: a zoonotic disease of global importance</article-title><source>Lancet Infect Dis</source><year>2003</year><volume>3</volume><fpage>757</fpage><lpage>771</lpage><pub-id pub-id-type="pmid">14652202</pub-id><pub-id pub-id-type="doi">10.1016/S1473-3099(03)00830-2</pub-id></citation></ref><ref id="B5"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pappas</surname><given-names>G</given-names></name><name><surname>Papadimitriou</surname><given-names>P</given-names></name><name><surname>Siozopoulou</surname><given-names>V</given-names></name><name><surname>Christou</surname><given-names>L</given-names></name><name><surname>Akritidis</surname><given-names>N</given-names></name></person-group><article-title>The globalization of leptospirosis: worldwide incidence trends</article-title><source>Int J Infect Dis</source><year>2008</year><volume>12</volume><fpage>351</fpage><lpage>357</lpage><pub-id pub-id-type="pmid">18055245</pub-id><pub-id pub-id-type="doi">10.1016/j.ijid.2007.09.011</pub-id></citation></ref><ref id="B6"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sejvar</surname><given-names>J</given-names></name><name><surname>Bancroft</surname><given-names>E</given-names></name><name><surname>Winthrop</surname><given-names>K</given-names></name><name><surname>Bettinger</surname><given-names>J</given-names></name><name><surname>Bajani</surname><given-names>M</given-names></name><name><surname>Bragg</surname><given-names>S</given-names></name><name><surname>Shutt</surname><given-names>K</given-names></name><name><surname>Kaiser</surname><given-names>R</given-names></name><name><surname>Marano</surname><given-names>N</given-names></name><name><surname>Popovic</surname><given-names>T</given-names></name><name><surname>Tappero</surname><given-names>J</given-names></name><name><surname>Ashford</surname><given-names>D</given-names></name><name><surname>Mascola</surname><given-names>L</given-names></name><name><surname>Vugia</surname><given-names>D</given-names></name><name><surname>Perkins</surname><given-names>B</given-names></name><name><surname>Rosenstein</surname><given-names>N</given-names></name><collab>Eco-Challenge Investigation Team</collab></person-group><article-title>Leptospirosis in "Eco-Challenge" athletes, Malaysian Borneo, 2000</article-title><source>Emerg Infect Dis</source><year>2003</year><volume>9</volume><fpage>702</fpage><lpage>707</lpage><pub-id pub-id-type="pmid">12781010</pub-id></citation></ref><ref id="B7"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sonrier</surname><given-names>C</given-names></name><name><surname>Branger</surname><given-names>C</given-names></name><name><surname>Michel</surname><given-names>V</given-names></name><name><surname>Ruvo&#x000eb;n-Clouet</surname><given-names>N</given-names></name><name><surname>Gani&#x000e8;re</surname><given-names>JP</given-names></name><name><surname>Andr&#x000e9;-Fontaine</surname><given-names>G</given-names></name></person-group><article-title>Evidence of cross-protection within <italic>Leptospira interrogans </italic>in an experimental model</article-title><source>Vaccine</source><year>2000</year><volume>19</volume><fpage>86</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">10924790</pub-id><pub-id pub-id-type="doi">10.1016/S0264-410X(00)00129-8</pub-id></citation></ref><ref id="B8"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koizumi</surname><given-names>N</given-names></name><name><surname>Watanabe</surname><given-names>H</given-names></name></person-group><article-title>Leptospirosis vaccines: past, present, and future</article-title><source>J Postgrad Med</source><year>2005</year><volume>51</volume><fpage>210</fpage><lpage>214</lpage><pub-id pub-id-type="pmid">16333195</pub-id></citation></ref><ref id="B9"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Campagnolo</surname><given-names>ER</given-names></name><name><surname>Warwick</surname><given-names>MC</given-names></name><name><surname>Marx</surname><given-names>HL</given-names><suffix>Jr</suffix></name><name><surname>Cowart</surname><given-names>RP</given-names></name><name><surname>Donnell</surname><given-names>HD</given-names><suffix>Jr</suffix></name><name><surname>Bajani</surname><given-names>MD</given-names></name><name><surname>Bragg</surname><given-names>SL</given-names></name><name><surname>Esteban</surname><given-names>JE</given-names></name><name><surname>Alt</surname><given-names>DP</given-names></name><name><surname>Tappero</surname><given-names>JW</given-names></name><name><surname>Bolin</surname><given-names>CA</given-names></name><name><surname>Ashford</surname><given-names>DA</given-names></name></person-group><article-title>Analysis of the 1998 outbreak of leptospirosis in Missouri in humans exposed to infected swine</article-title><source>J Am Vet Med Assoc</source><year>2000</year><volume>216</volume><fpage>676</fpage><lpage>682</lpage><pub-id pub-id-type="pmid">10707682</pub-id><pub-id pub-id-type="doi">10.2460/javma.2000.216.676</pub-id></citation></ref><ref id="B10"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Venkataraman</surname><given-names>KS</given-names></name><name><surname>Nedunchelliyan</surname><given-names>S</given-names></name></person-group><article-title>Epidemiology of an outbreak of leptospirosis in man and dog</article-title><source>Comp Immunol Microbiol Infect Dis</source><year>1992</year><volume>15</volume><fpage>243</fpage><lpage>247</lpage><pub-id pub-id-type="pmid">1424559</pub-id><pub-id pub-id-type="doi">10.1016/0147-9571(92)90003-A</pub-id></citation></ref><ref id="B11"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gong</surname><given-names>ZY</given-names></name><name><surname>Jiang</surname><given-names>LP</given-names></name><name><surname>Chen</surname><given-names>EF</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>JF</given-names></name><name><surname>Fu</surname><given-names>GM</given-names></name><name><surname>Cai</surname><given-names>CL</given-names></name><name><surname>Xu</surname><given-names>FH</given-names></name></person-group><article-title>Epidemiological surveillance of leptospirosis in 1997&#x02013;2002 in Zhejiang Province</article-title><source>Zhonghua Liu Xing Bing Xue Za Zhi</source><year>2004</year><volume>25</volume><fpage>1091</fpage><pub-id pub-id-type="pmid">15769379</pub-id></citation></ref><ref id="B12"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>MH</given-names></name><name><surname>Tu</surname><given-names>YR</given-names></name><name><surname>Li</surname><given-names>QJ</given-names></name></person-group><article-title>Study on geographical distribution of leptospirosis in China</article-title><source>Zhonghua Liu Xing Bing Xue Za Zhi</source><year>1995</year><volume>16</volume><fpage>259</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">8706089</pub-id></citation></ref><ref id="B13"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Martinez</surname><given-names>R</given-names></name><name><surname>Perez</surname><given-names>A</given-names></name><name><surname>Quinones Mdel</surname><given-names>C</given-names></name><name><surname>Cruz</surname><given-names>R</given-names></name><name><surname>Alvarez</surname><given-names>A</given-names></name><name><surname>Armesto</surname><given-names>M</given-names></name><name><surname>Fern&#x000e1;ndez</surname><given-names>C</given-names></name><name><surname>Men&#x000e9;ndez</surname><given-names>J</given-names></name><name><surname>Rodr&#x000ed;guez</surname><given-names>I</given-names></name><name><surname>Bar&#x000f3;</surname><given-names>M</given-names></name><name><surname>D&#x000ed;az</surname><given-names>M</given-names></name><name><surname>Rodr&#x000ed;guez</surname><given-names>J</given-names></name><name><surname>Sierra</surname><given-names>G</given-names></name><name><surname>Obreg&#x000f3;n</surname><given-names>AM</given-names></name><name><surname>Toledo</surname><given-names>ME</given-names></name><name><surname>Fern&#x000e1;ndez</surname><given-names>N</given-names></name></person-group><article-title>Efficacy and safety of a vaccine against human leptospirosis in Cuba</article-title><source>Rev Panam Salud Publica</source><year>2004</year><volume>15</volume><fpage>249</fpage><lpage>255</lpage><pub-id pub-id-type="pmid">15193180</pub-id><pub-id pub-id-type="doi">10.1590/S1020-49892004000400005</pub-id></citation></ref><ref id="B14"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Liou</surname><given-names>W</given-names></name><name><surname>Ding</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>A</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Gao</surname><given-names>Z</given-names></name><name><surname>Ye</surname><given-names>X</given-names></name><name><surname>Xiao</surname><given-names>Y</given-names></name></person-group><article-title>An evaluation of the serological and epidemiological effects of the outer envelope vaccine to <italic>Leptospira </italic></article-title><source>J Chin Med Assoc</source><year>2003</year><volume>66</volume><fpage>224</fpage><lpage>230</lpage><pub-id pub-id-type="pmid">12854874</pub-id></citation></ref><ref id="B15"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rathinam</surname><given-names>SR</given-names></name></person-group><article-title>Ocular leptospirosis</article-title><source>Curr Opin Ophthalmol</source><year>2002</year><volume>13</volume><fpage>381</fpage><lpage>386</lpage><pub-id pub-id-type="pmid">12441841</pub-id><pub-id pub-id-type="doi">10.1097/00055735-200212000-00007</pub-id></citation></ref><ref id="B16"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haake</surname><given-names>DA</given-names></name><name><surname>Champion</surname><given-names>CI</given-names></name><name><surname>Marfinich</surname><given-names>C</given-names></name><name><surname>Shang</surname><given-names>ES</given-names></name><name><surname>Blanco</surname><given-names>DR</given-names></name><name><surname>Miller</surname><given-names>JN</given-names></name><name><surname>Lovett</surname><given-names>MA</given-names></name></person-group><article-title>Molecular cloning and sequence analysis of the gene encoding OmpL1, a transmembrane outer membrane protein of pathogenic <italic>Leptospira </italic>spp</article-title><source>J Bacteriol</source><year>1993</year><volume>175</volume><fpage>4225</fpage><lpage>4234</lpage><pub-id pub-id-type="pmid">8320237</pub-id></citation></ref><ref id="B17"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shang</surname><given-names>ES</given-names></name><name><surname>Exner</surname><given-names>MM</given-names></name><name><surname>Summers</surname><given-names>TA</given-names></name><name><surname>Martinich</surname><given-names>C</given-names></name><name><surname>Champion</surname><given-names>CI</given-names></name><name><surname>Hancock</surname><given-names>RE</given-names></name><name><surname>Haake</surname><given-names>DA</given-names></name></person-group><article-title>The rare outer membrane protein, OmpL1, of pathogenic <italic>Leptospira </italic>species is a heat-modifiable porin</article-title><source>Infect Immun</source><year>1995</year><volume>63</volume><fpage>3174</fpage><lpage>3181</lpage><pub-id pub-id-type="pmid">7622245</pub-id></citation></ref><ref id="B18"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haake</surname><given-names>DA</given-names></name><name><surname>Mazel</surname><given-names>MK</given-names></name><name><surname>McCoy</surname><given-names>AM</given-names></name><name><surname>Milward</surname><given-names>F</given-names></name><name><surname>Chao</surname><given-names>G</given-names></name><name><surname>Matsunaga</surname><given-names>J</given-names></name><name><surname>Wagar</surname><given-names>EA</given-names></name></person-group><article-title>Leptospiral outer membrane proteins OmpL1 and LipL41 exhibit synergistic immunoprotection</article-title><source>Infect Immun</source><year>1999</year><volume>67</volume><fpage>6572</fpage><lpage>6582</lpage><pub-id pub-id-type="pmid">10569777</pub-id></citation></ref><ref id="B19"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haake</surname><given-names>DA</given-names></name><name><surname>Suchard</surname><given-names>MA</given-names></name><name><surname>Kelley</surname><given-names>MM</given-names></name><name><surname>Dundoo</surname><given-names>M</given-names></name><name><surname>Alt</surname><given-names>DP</given-names></name><name><surname>Zuerner</surname><given-names>RL</given-names></name></person-group><article-title>Molecular evolution and mosicism of leptospiral outer membrane proteins involves horizontal DNA transfer</article-title><source>J Bateriol</source><year>2004</year><volume>186</volume><fpage>2818</fpage><lpage>2128</lpage><pub-id pub-id-type="doi">10.1128/JB.186.9.2818-2828.2004</pub-id></citation></ref><ref id="B20"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sonrier</surname><given-names>C</given-names></name><name><surname>Branger</surname><given-names>C</given-names></name><name><surname>Michel</surname><given-names>V</given-names></name><name><surname>Ruvo&#x000eb;n-Clouet</surname><given-names>N</given-names></name><name><surname>Gani&#x000e8;re</surname><given-names>JP</given-names></name><name><surname>Andr&#x000e9;-Fontaine</surname><given-names>G</given-names></name></person-group><article-title>Evidence of cross-protection within Leptospira interrogans in an experimental model</article-title><source>Vaccine</source><year>2000</year><volume>19</volume><fpage>86</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">10924790</pub-id><pub-id pub-id-type="doi">10.1016/S0264-410X(00)00129-8</pub-id></citation></ref><ref id="B21"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cullen</surname><given-names>PA</given-names></name><name><surname>Cordwell</surname><given-names>SJ</given-names></name><name><surname>Bulach</surname><given-names>DM</given-names></name><name><surname>Haake</surname><given-names>DA</given-names></name><name><surname>Adler</surname><given-names>B</given-names></name></person-group><article-title>Global analysis of outer membraneproteins from Leptospira interrogans serovar Lai</article-title><source>Infect Immun</source><year>2002</year><volume>70</volume><fpage>2311</fpage><lpage>2318</lpage><pub-id pub-id-type="pmid">11953365</pub-id><pub-id pub-id-type="doi">10.1128/IAI.70.5.2311-2318.2002</pub-id></citation></ref><ref id="B22"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cullen</surname><given-names>PA</given-names></name><name><surname>Haake</surname><given-names>DA</given-names></name><name><surname>Adler</surname><given-names>B</given-names></name></person-group><article-title>Outer membrane proteins of pathogenic spirochetes</article-title><source>FEMS Microbiol Rev</source><year>2004</year><volume>28</volume><fpage>291</fpage><lpage>318</lpage><pub-id pub-id-type="pmid">15449605</pub-id><pub-id pub-id-type="doi">10.1016/j.femsre.2003.10.004</pub-id></citation></ref><ref id="B23"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Palaniappan</surname><given-names>RU</given-names></name><name><surname>Ramanujam</surname><given-names>S</given-names></name><name><surname>Chang</surname><given-names>YF</given-names></name></person-group><article-title>Leptospirosis: pathogenesis, immunity, and diagnosis</article-title><source>Curr Opin Infect Dis</source><year>2007</year><volume>20</volume><fpage>284</fpage><lpage>292</lpage><pub-id pub-id-type="pmid">17471039</pub-id><pub-id pub-id-type="doi">10.1097/QCO.0b013e32814a5729</pub-id></citation></ref><ref id="B24"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>XY</given-names></name><name><surname>Yu</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>P</given-names></name><name><surname>Zhang</surname><given-names>YX</given-names></name><name><surname>Hu</surname><given-names>BY</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Nie</surname><given-names>YX</given-names></name><name><surname>Jiang</surname><given-names>XG</given-names></name><name><surname>Zhao</surname><given-names>GP</given-names></name><name><surname>Guo</surname><given-names>XK</given-names></name></person-group><article-title>Expression and comparative analysis of genes encoding outer membrane proteins LipL21, LipL32 and OmpL1 in epidemic leptospires</article-title><source>Acta Biochim Biophys Sin</source><year>2005</year><volume>37</volume><fpage>649</fpage><lpage>656</lpage><pub-id pub-id-type="pmid">16215631</pub-id><pub-id pub-id-type="doi">10.1111/j.1745-7270.2005.00094.x</pub-id></citation></ref><ref id="B25"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dai</surname><given-names>B</given-names></name></person-group><article-title>Advances in research on <italic>leptospira </italic>and human leptospirosis in China</article-title><source>Chin Med Sci J</source><year>1992</year><volume>7</volume><fpage>239</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">1307502</pub-id></citation></ref><ref id="B26"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kobayashi</surname><given-names>Y</given-names></name></person-group><article-title>Clinical observation and treatment of leptospirosis</article-title><source>J Infect Chemother</source><year>2001</year><volume>7</volume><fpage>59</fpage><lpage>68</lpage><pub-id pub-id-type="pmid">11455495</pub-id><pub-id pub-id-type="doi">10.1007/s101560100011</pub-id></citation></ref><ref id="B27"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>JD</given-names></name><name><surname>Gibson</surname><given-names>TJ</given-names></name><name><surname>Plewniak</surname><given-names>F</given-names></name><name><surname>Jeanmougin</surname><given-names>F</given-names></name><name><surname>Higgins</surname><given-names>DG</given-names></name></person-group><article-title>The Clustsal X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools</article-title><source>Nucleic Acids Res</source><year>1997</year><volume>24</volume><fpage>4876</fpage><lpage>4882</lpage><pub-id pub-id-type="pmid">9396791</pub-id><pub-id pub-id-type="doi">10.1093/nar/25.24.4876</pub-id></citation></ref><ref id="B28"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Swofford</surname><given-names>DL</given-names></name></person-group><source><italic>PAUP </italic>*: Phylogenetic analysis using parsimony (*and other methods)</source><year>2002</year><publisher-name>Sunderland, Massachusetts, USA: Sinauer Associates</publisher-name><pub-id pub-id-type="pmid">12504223</pub-id></citation></ref><ref id="B29"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>S</given-names></name><name><surname>Tamura</surname><given-names>K</given-names></name><name><surname>Nei</surname><given-names>M</given-names></name></person-group><article-title>MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment</article-title><source>Brief Bioinform</source><year>2004</year><volume>5</volume><fpage>150</fpage><lpage>163</lpage><pub-id pub-id-type="pmid">15260895</pub-id><pub-id pub-id-type="doi">10.1093/bib/5.2.150</pub-id></citation></ref><ref id="B30"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chou</surname><given-names>PY</given-names></name><name><surname>Fasman</surname><given-names>GD</given-names></name></person-group><article-title>Prediction of secondary structure of proteins from their amino acid sequence</article-title><source>Adv Enzymol Relat Areas Mol Biol</source><year>1978</year><volume>47</volume><fpage>145</fpage><lpage>148</lpage></citation></ref><ref id="B31"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kyte</surname><given-names>J</given-names></name><name><surname>Doolittle</surname><given-names>RF</given-names></name></person-group><article-title>A simple method for displaying the hydropathic character of a protein</article-title><source>J Mol Biol</source><year>1982</year><volume>157</volume><fpage>105</fpage><lpage>132</lpage><pub-id pub-id-type="pmid">7108955</pub-id><pub-id pub-id-type="doi">10.1016/0022-2836(82)90515-0</pub-id></citation></ref><ref id="B32"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jameson</surname><given-names>BA</given-names></name><name><surname>Wolf</surname><given-names>H</given-names></name></person-group><article-title>The antigenic index: a novel algorithm for predicting antigenic determinants</article-title><source>Comput Appl Biosci</source><year>1988</year><volume>4</volume><fpage>181</fpage><lpage>186</lpage><pub-id pub-id-type="pmid">2454713</pub-id></citation></ref><ref id="B33"><citation citation-type="book"><person-group person-group-type="author"><name><surname>Sambrook</surname><given-names>J</given-names></name><name><surname>Fritsch</surname><given-names>EF</given-names></name><name><surname>Maniatis</surname><given-names>T</given-names></name></person-group><source>Molecular cloning, a laboratory manual</source><year>1989</year><publisher-name>New York, USA: Cold Spring Harbor Laboratory Press</publisher-name></citation></ref><ref id="B34"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>SM</given-names></name><name><surname>Osei-Bimpong</surname><given-names>A</given-names></name></person-group><article-title>Haemoglobinometry in general practice</article-title><source>Clin Lab Haematol</source><year>2003</year><volume>25</volume><fpage>343</fpage><lpage>346</lpage><pub-id pub-id-type="pmid">14641136</pub-id><pub-id pub-id-type="doi">10.1046/j.0141-9854.2003.00553.x</pub-id></citation></ref><ref id="B35"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Ojcius</surname><given-names>DM</given-names></name><name><surname>Yan</surname><given-names>J</given-names></name></person-group><article-title>Comparison of invasion of fibroblasts and macrophages by high- and low-virulence Leptospira strains: colonization of the host-cell nucleus and induction of necrosis by the virulent strain</article-title><source>Arch Microbiol</source><year>2007</year><volume>188</volume><fpage>591</fpage><lpage>598</lpage><pub-id pub-id-type="pmid">17622516</pub-id><pub-id pub-id-type="doi">10.1007/s00203-007-0280-3</pub-id></citation></ref><ref id="B36"><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Levesque</surname><given-names>PM</given-names></name><name><surname>Foster</surname><given-names>K</given-names></name><name><surname>de Alwis</surname><given-names>U</given-names></name></person-group><article-title>Association between immunogenicity and adsorption of a recombinant Streptococcus pneumomiae vaccine antigen by aluminum adjuvant</article-title><source>Hum Vaccin</source><year>2006</year><volume>2</volume><fpage>74</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">17012880</pub-id></citation></ref></ref-list></back></article>